SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Beasley Broadcast Group, Inc. is multi-platform media company, which engages in the operation of radio stations in the United States. The firm offers marketing solutions across event platforms. It operates through the following business segments: Audio, Digital, and Other. The company was founded by George G. Beasley in 1961 and is headquartered in Naples, FL.

Beasley Broadcast Group Inc - Ordinary Shares - Class A

BBGI is trending due to a wild run-up, leading to multiple trading halts, and the community is debating whether to hold through after-hours for potential gains. Some traders believe a short squeeze is in play, while others are wary of a potential pullback. The stock's volatility and low float are key discussion points.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix ($NFLX) is trending amid speculation about a potential acquisition of Warner Bros. Discovery ($WBD), with recent price action reflecting market uncertainty and deal complexities. Community discussions revolve around the potential outcomes of the acquisition, including concerns about debt and market competition, as well as alternative scenarios where Netflix remains independent.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending as the market anticipates the Fed's rate decision and Powell's press conference, with community members debating the potential impact on the market's direction. Discussions revolve around whether the Fed will cut rates, the possibility of QE, and the implications of a hawkish or dovish stance. Some traders are also noting news of the U.S. seizing an oil tanker off Venezuela, adding another layer of uncertainty.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending amid expectations surrounding the Fed's rate decision and commentary on future monetary policy, with potential implications for AI spending. Community members are actively discussing possible market reactions and impacts of a rate cut, and some express concerns about the Fed's influence. Traders are closely watching key levels and anticipating volatility, while also debating the influence of AI on the economy.

Mawson Infrastructure Group, Inc. engages in the provision of digital asset infrastructure services. The company was founded on February 10, 2012 and is headquartered in Midland, PA.

Mawson Infrastructure Group Inc

Mawson Infrastructure Group (MIGI) is trending due to anticipation surrounding its presentation at the Emerging Growth Conference, with discussions focusing on its growth strategy in bitcoin mining and AI infrastructure. Community members are actively speculating on potential catalysts from the conference, particularly updates on contracts and corporate developments. With a tiny float, MIGI is also recognized for its volatility and potential for explosive moves, especially given its expansion into power capacity, colocation services, and AI/GPU hosting pilots.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending as community members discuss its failure to keep pace with broader market gains and its underperformance relative to other tech giants. Some speculate on potential shifts in AI partnerships and the impact of competition from Google, while others point to institutional accumulation and long-term growth potential. The stock's struggle to surpass key resistance levels is also a focal point of discussion.

BlackRock Institutional Trust Company N.A. - iShares Russell 2000 ETF

iShares Russell 2000 ETF

IWM is trending as traders discuss the potential for new all-time highs amid a possible rotation into small caps and anticipation surrounding the upcoming Fed meeting and potential rate cuts. Community members are actively trading options, with bullish and bearish sentiment reflected in discussions around calls and puts, while the index flirts with resistance levels. Some analysts suggest that small caps may outperform in 2026, while others express concern about a potential pullback.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with Mobility Drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, or taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting Carriers with Shippers on its platform, and gives Carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Traders are actively discussing whether to buy the dip in UBER, as the stock experiences a significant pullback. Community talking points include the company's long-term growth potential and strong cash flow, while some express concerns about increased competition in the autonomous vehicle space and potential algorithm adjustments in Europe. Despite the concerns, many view the pullback as an overreaction and a buying opportunity, citing the company's established brand and partnerships.

Biodexa Pharmaceuticals Plc is a drug delivery technology company. It is focused on the research and development of medicines for rare cancers, via both in-house programs as well as partnered programs. The firm's proprietary platform drug delivery technologies are Q-Sphera platform is a disruptive polymer microsphere technology, which is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months; Midasolve platform is an innovative nano saccharide technology, which is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumors; Midacore platform is an edge gold nanoparticle technology, which is used for targeting sites of disease at the nanoscale. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.

Biodexa Pharmaceuticals Plc - ADR

Biodexa Pharmaceuticals Plc

Biodexa Pharmaceuticals (BDRX) is trending as traders discuss its potential for a squeeze, citing its low float and the past performance of similar stocks. Community members are actively monitoring price movements and debating entry/exit strategies. Some traders are pointing to catalysts while others warn of potential dilution.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as investors discuss a potential FDA approval for its oral weight-loss pill before year-end, while also weighing the competitive landscape with Eli Lilly. Community discussions revolve around potential price targets and the impact of political factors on regulatory decisions. Recent analyst ratings and potential acquisitions are also being closely monitored.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Coya Therapeutics' (COYA) "Buy" Rating Reaffirmed at D. Boral Capital

D. Boral Capital reiterated a "buy" rating and set a $15.00 target price on shares of Coya Therapeutics in a research report on Tuesday...

Coya Therapeutics Announces Patients Have Been Dosed in the ALSTARS Trial of COYA 302 for the Treatment of ALS

Coya Therapeutics, Inc. (NASDAQ: COYA) (Coya or the Company), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with...

Coya Therapeutics, Inc. (NASDAQ:COYA) Given Consensus Rating of "Moderate Buy" by Brokerages

Coya Therapeutics, Inc. (NASDAQ:COYA - Get Free Report) has been assigned an average rating of "Moderate Buy" from the six analysts that are presently covering the stock, MarketBeat reports. One...

Coya Therapeutics (NASDAQ:COYA) Receives "Buy" Rating from Chardan Capital

Chardan Capital restated a "buy" rating and issued a $14.00 target price on shares of Coya Therapeutics in a report on Friday...

Coya Therapeutics (NASDAQ:COYA) Rating Increased to Hold at Wall Street Zen

Wall Street Zen raised Coya Therapeutics from a "sell" rating to a "hold" rating in a research note on Saturday...

Coya Therapeutics (NASDAQ:COYA) Stock Price Expected to Rise, BTIG Research Analyst Says

BTIG Research increased their price objective on Coya Therapeutics from $15.00 to $16.00 and gave the company a "buy" rating in a research note on Thursday...

Coya Therapeutics (NASDAQ:COYA) Receives Buy Rating from D. Boral Capital

D. Boral Capital reissued a "buy" rating and set a $15.00 price target on shares of Coya Therapeutics in a research note on Wednesday...

Coya Therapeutics (NASDAQ:COYA) Releases Earnings Results, Misses Estimates By $0.12 EPS

Coya Therapeutics (NASDAQ:COYA - Get Free Report) announced its earnings results on Wednesday. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts' consensus...

Coya Therapeutics Reports Third Quarter Financial Results and Provides a Corporate Update

Coya Therapeutics Announces That Its Combination LD IL-2/GLP-1 RA Candidate (COYA 303) Demonstrated Potent Systemic and Brain Anti-Inflammatory Efficacy In Vivo

Coya Therapeutics, Inc. (NASDAQ: COYA) (Coya or the Company), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, today announced...

Coya Therapeutics, Inc. is a clinical-stage biotechnology company which engages in developing proprietary medicinal products to modulate the function of regulatory T cells. The company was founded by Howard Berman in 2020 and is headquartered in Houston, TX.

Coya Therapeutics Inc

Bullish: S&P grinds higher

Choppy but up: buy dips

Sideways: fade the move

Bearish: this rally falls off

The Federal Reserve just announced a 0.25 percentage point interest rate cut at its December 10, 2025 meeting.​ Share your outlook on how the latest Federal Reserve interest rate cut will impact stocks and the S&P 500 over the next month.

How do you think today’s Fed rate cut impacts stocks over the next month?

COYA
Coya Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest COYA News

COYACoya Therapeutics Inc